Literature DB >> 19056494

Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome.

Topi A Tervonen1, Verna Louhivuori, Xiaohong Sun, Marie-Estelle Hokkanen, Claudius F Kratochwil, Pawel Zebryk, Eero Castrén, Maija L Castrén.   

Abstract

The lack of fragile X mental retardation protein (FMRP) causes fragile X syndrome, a common form of inherited mental retardation. Our previous studies revealed alterations in the differentiation of FMRP-deficient neural progenitors. Here, we show abnormalities in neurogenesis in the mouse and human embryonic FMRP-deficient brain as well as after in utero transfection of I304N mutated FMRP, which acts in a dominant negative manner in the wild-type mouse brain. Progenitors accumulated abnormally in the subventricular zone of the embryonic Fmr1-knockout (Fmr1-KO) mouse neocortex. An increased density of cells expressing sequentially an intermediate progenitor marker, T-box transcription factor (Tbr2), and a postmitotic neuron marker, T-brain 1 (Tbr1), indicated that the differentiation to glutamatergic cell lineages was particularly disturbed. These abnormalities were associated with an increased density of pyramidal cells of the layer V in the early postnatal neocortex suggesting a role for FMRP in the regulation of the differentiation of neocortical glutamatergic neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056494     DOI: 10.1016/j.nbd.2008.10.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  40 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Fragile X protein controls neural stem cell proliferation in the Drosophila brain.

Authors:  Matthew A Callan; Clemens Cabernard; Jennifer Heck; Samantha Luois; Chris Q Doe; Daniela C Zarnescu
Journal:  Hum Mol Genet       Date:  2010-05-26       Impact factor: 6.150

3.  Translational regulation of NeuroD1 expression by FMRP: involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cells.

Authors:  Se Jin Jeon; Ji-Woon Kim; Ki Chan Kim; So Min Han; Hyo Sang Go; Jung Eun Seo; Chang Soon Choi; Jong Hoon Ryu; Chan Young Shin; Mi-Ryoung Song
Journal:  Cell Mol Neurobiol       Date:  2013-12-12       Impact factor: 5.046

4.  Neural precursor lineages specify distinct neocortical pyramidal neuron types.

Authors:  William A Tyler; Maria Medalla; Teresa Guillamon-Vivancos; Jennifer I Luebke; Tarik F Haydar
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 5.  Treatment of neurodevelopmental disorders in adulthood.

Authors:  Eero Castrén; Ype Elgersma; Lamberto Maffei; Randi Hagerman
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

6.  FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry.

Authors:  Giorgio La Fata; Annette Gärtner; Nuria Domínguez-Iturza; Tom Dresselaers; Julia Dawitz; Rogier B Poorthuis; Michele Averna; Uwe Himmelreich; Rhiannon M Meredith; Tilmann Achsel; Carlos G Dotti; Claudia Bagni
Journal:  Nat Neurosci       Date:  2014-11-17       Impact factor: 24.884

7.  Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.

Authors:  Michael J Boland; Kristopher L Nazor; Ha T Tran; Attila Szücs; Candace L Lynch; Ryder Paredes; Flora Tassone; Pietro Paolo Sanna; Randi J Hagerman; Jeanne F Loring
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

8.  RNA-binding protein FXR2 regulates adult hippocampal neurogenesis by reducing Noggin expression.

Authors:  Weixiang Guo; Li Zhang; Devin M Christopher; Zhao-Qian Teng; Sarah R Fausett; Changmei Liu; Olivia L George; John Klingensmith; Peng Jin; Xinyu Zhao
Journal:  Neuron       Date:  2011-06-09       Impact factor: 17.173

9.  The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.

Authors:  David J Brick; Hubert E Nethercott; Samantha Montesano; Maria G Banuelos; Alexander E Stover; Soleil Sun Schutte; Diane K O'Dowd; Randi J Hagerman; Michele Ono; David R Hessl; Flora Tassone; Philip H Schwartz
Journal:  Stem Cells Transl Med       Date:  2014-10-01       Impact factor: 6.940

10.  Open-label memantine in fragile X syndrome.

Authors:  Craig A Erickson; Jennifer E Mullett; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.